In vitro time-kill studies of antibacterial agents from putative marine Streptomyces species isolated from the Nahoon beach, South Africa

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 12, 2010, Pages 908-916

  Ogunmwonyi, Isoken H ^a   Mazomba, Ntsikelelo ^a   Mabinya, Leonard ^a   Ngwenya, Elvis ^a   Green, Ezekiel ^a   Akinpelu, David A ^b   Olaniran, Ademola O ^c   Okoh, Anthony I ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antibacterial compounds; Marine streptomyces; Nahoon beach; Time kill

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIOSTASIS; BACTERIUM ISOLATE; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; IN VITRO STUDY; MARINE SPECIES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SOUTH AFRICA; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE; STREPTOMYCES;

EID: 79951789062     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Atta HH, Dabour SM, Desoukey SG (2009). Sparsomycin antibiotic production by Streptomyces sp. AZ-NIOFD1: taxonomy, fermentation, purification and biological activities American-Eurasian. J. Agric. Environ. Sci., 5: 368-377.
2. CLSI (2006). Clinical and Laboratory Standard Institute. Performance standard for antimicrobial susceptibility testing; sixteenth informational supplement. M100-S16, 26: 15-130
3. De Vries DJ, Beart PM (1995). Fishing for drugs from the sea: status and strategies. Trends Pharmacol. Sci., 16: 275-279.
4. Donay JL, Fernandes P, Lagrange PH, Herrmann JL (2007). Evaluation of the Inoculation Procedure Using a 0.25 McFarland Standard for the BD Phoenix Automated Microbiology System. J. Clin. Microbiol., 12: 4088-4089.
5. El-Gendy MAA, Shaaban M, EL-Bondkly AM, Shaaban KA (2008a). Bioactive benzopyrone derivatives from new recombinant fusant of marine Streptomyces. Appl. Biochem. Biotechnol., 150: 85-96.
6. El-Gendy MAA, Shaaban M, Shaaban KA, El-Bondkly AM, Laatsch H (2008b). Essramycin: a first triazolopyrimidine antibiotic isolated from nature. J. Antibiot., 61: 149-157.
7. Ellof JN (1998). A sensitive and quick micro plate method to determine the minimal inhibitory concentration of plant extract for bacteria. Plant Medica, 64: 711-713.
8. Elward AM, McAndrews JM, Young VL (2009). Methicillin-sensitive and methicillin-resistant Staphylococcus aureus: preventing surgical site infections following plastic surgery. Aesthetic Surg. J., 29: 232-244.
9. Gerwick WH, Bernart MW (1993). Eicosanoids and related compounds from marine algae. In Marine biotechnology. pharmaceutical and bioactive natural product Attaway, D.H., Zaborsky, O.R., Eds.; Plenum Press, NY., 1: 101-152.
10. Ghanem NB, Sabry SA, El-Sherif ZM, Abu El-Ela GA (2000). Isolation and enumeration of marine actinomycetes from seawater and sediments in Alexandria. J. Gen. Appl. Microbiol., 46: 105-111.
11. Gould FK, Brindle R, Chadwick PR, Fraise AP, Hill S, Nathwani D, Ridgway GL, Spry MJ, Warren RE (2009). On behalf of the MRSA Working Party of the British. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J. Antimicrob. Chemother., 63: 849- 861.
12. Hou Y, Lia F, Wangd S, Qina S, Quan-Fu, Wang Q (2006). Intergeneric conjugation in holomycin-producing marine Streptomyces sp. strain M095. Microbiol. Res., 163: 96-104.
13. Ilic SB, Konstantinovic SS, Todorovic ZB, Lazic ML, Veljkovic VB, Jokovic N, Radovanovic BC (2007). Characterization and antimicrobial activity of the bioactive metabolites in Streptomycete isolates. Microbiol., 76: 421-428.
14. Isnansetyo A, Kamei Y (2003). MC21-A, a Bactericidal antibiotic produced by a new, marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against methicillin- resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 47: 480-488.
15. Mahyudin NA (2008). Actinomycetes and fungi associated with marine invertebrates: a potential source of bioactive compounds. Doctor of Philosophy in Microbiology at the University of Canterbury.
16. Ogunmwonyi INH (2008). Actinomycetes diversity of Nahoon beach and Tyume River. Honours dissertation submitted to the department of Biochemistry and Microbiology, University of Fort Hare, Alice, South Africa.
17. Pankuch GA, Jacobs MR, Appelbaum PC (1996). MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 5950 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci. Antimicrob. Agents Chemother., 40: 2071-2074.
18. Saha B, Singh AK, Ghosh A, Bal M (2008). Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J. Med. Microbiol., 57: 72-79.
19. Schmidt S, Sabarinath SN, Barbour A, Abbanat D, Manitpisitkul P, Sha S, Derendorf H (2009). Pharmacokinetic-pharmacodynamic modeling of the in vitro activities ofoxazolidinoneantimicrobial agents against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother., 53: 5039-5045.
20. Sonavane A, De A, Mathur M (2007). Screening for vancomycin intermediate-resistant Staphylococcus aureus among clinical isolates of MRSA. Indian J. Med. Microbiol. 25: 79-80.
21. Spangler SK, Jacobs MR, Appelbaum PC (1997). Bactericidal activity of DU-6859 as compared to activities of three quinolones, three - Lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology. Antimicrob. Agents Chemother., 41: 847-849.
22. Tam VH, Schilling AN, Nikolaou M (2005). Modelling time-kill studies to discern the pharmacodynamics of meropenem. J. Antimicrob. Chemother., 55: 699-706.
23. Watanakunakorn C, Tisonel J (1982). Synergism between N- formimidoyl thienamycin and gentamicin or tobramycin against Enterococci. Antimicrob. Agents Chemother., 22: 1082-1083.